Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in children and adolescents, closely mirroring the global rise in childhood obesity.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in children and adolescents, closely mirroring the global rise in childhood obesity.